Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12557-12569

  Yoon, Joo Chun ^a   Lim, Jong Baeck ^a   Park, Jeon Han ^a   Lee, Jae Myun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D;

ARTICLE; CELL CONTACT; CELL INTERACTION; CELL LINE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; DEGRANULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; VIRION;

CARCINOMA, HEPATOCELLULAR; CELL COMMUNICATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; T-LYMPHOCYTES; VIRION;

HEPATITIS C VIRUS;

EID: 81255180037     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00838-11     Document Type: Article

References (41)

1. Ahlenstiel, G., et al. 2010. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138:325-335.
2. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294:15-22.
3. Amadei, B., et al. 2010. Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138:1536-1545.
4. Bengsch, B., et al. 2010. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog. 6:e1000947.
5. Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214:73-91.
6. Bull, M., et al. 2007. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 322:57-69.
7. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112:461-469.
8. Crotta, S., M. Brazzoli, D. Piccioli, N. M. Valiante, and A. Wack. 2010. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J. Hepatol. 52:183-190.
9. Crotta, S., et al. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195:35-41.
10. Gale, M., Jr., and E. M. Foy. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945.
11. Golden-Mason, L., et al. 2008. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57:1121-1128.
12. Herzer, K., et al. 2003. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J. Virol. 77:8299-8309.
13. Hoofnagle, J. H. 2002. Course and outcome of hepatitis C. Hepatology 36:S21-S29.
14. Jinushi, M., et al. 2005. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J. Hepatol. 43:1013-1020.
15. Jinushi, M., et al. 2004. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 173:6072-6081.
16. Jo, J., V. Lohmann, R. Bartenschlager, and R. Thimme. 2011. Experimental models to study the immunobiology of hepatitis C virus. J. Gen. Virol. 92:477-493.
17. Kato, T., et al. 2006. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1:2334-2339.
18. Krzewski, K., and J. L. Strominger. 2008. The killer's kiss: the many functions of NK cell immunological synapses. Curr. Opin. Cell Biol. 20:597-605. 19
19. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8:259-268.
20. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9:495-502.
21. Lindenbach, B. D., et al. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
22. Lodoen, M. B., and L. L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18:391-398.
23. Long, E. O. 2007. Ready for prime time: NK cell priming by dendritic cells. Immunity 26:385-387.
24. Moradpour, D., et al. 2001. Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro. Hepatology 33:1282-1287.
25. Muntasell, A., G. Magri, D. Pende, A. Angulo, and M. Lopez-Botet. 2010. Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood 115:5170-5179.
26. Nattermann, J., et al. 2006. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55:869-877. 27
27. Oliviero, B., et al. 2009. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137:1151-1160.
28. Rehermann, B. 2009. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119:1745-1754. 29.
29. Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5:215-229.
30. Sene, D., et al. 2010. Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog. 6:e1001184.
31. Stegmann, K. A., et al. 2010. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 138:1885-1897.
32. Strowig, T., F. Brilot, and C. Munz. 2008. Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J. Immunol. 180:7785-7791.
33. Strowig, T., et al. 2009. Priming of protective T cell responses against virusinduced tumors in mice with human immune system components. J. Exp. Med. 206:1423-1434.
34. Sumpter, R., Jr., et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
35. Tardif, K. D., and A. Siddiqui. 2003. Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells. J. Virol. 77:11644-11650.
36. Tseng, C. T., and G. R. Klimpel. 2002. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195:43-49.
37. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9:503-510.
38. Wakita, T., et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
39. Wiemann, K., et al. 2005. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 175:720-729.
40. Yoon, J. C., M. Shiina, G. Ahlenstiel, and B. Rehermann. 2009. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49:12-21.
41. Zhong, J., et al. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102:9294-9299.